Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Acadia Pharmaceuticals Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 245
- −27 vs. Q1 2021
- Shares held
- 148.0M
- +2.65M (+1.8%) vs. Q1 2021
- Total value
- $3.61B
- −$148.1M (−3.9%) vs. Q1 2021
- New holders
- 41
- 86 more added
- Sold out
- 68
- 72 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACAD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 353 | $4.27B |
| Q1 2026 | 343 | $3.67B |
| Q4 2025 | 336 | $4.44B |
| Q3 2025 | 334 | $3.58B |
| Q2 2025 | 311 | $3.66B |
| Q1 2025 | 320 | $2.87B |
| Q4 2024 | 296 | $2.99B |
| Q3 2024 | 258 | $2.41B |
| Q2 2024 | 265 | $2.62B |
| Q1 2024 | 268 | $2.99B |
| Q4 2023 | 277 | $4.99B |
| Q3 2023 | 249 | $3.25B |
| Q2 2023 | 236 | $3.81B |
| Q1 2023 | 234 | $2.97B |
| Q4 2022 | 228 | $2.48B |
| Q3 2022 | 223 | $2.49B |
| Q2 2022 | 246 | $2.13B |
| Q1 2022 | 262 | $3.56B |
| Q4 2021 | 247 | $3.46B |
| Q3 2021 | 238 | $2.41B |
| Q2 2021 | 245 | $3.61B |
| Q1 2021 | 272 | $3.76B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Acadia Pharmaceuticals Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manchester Financial Inc | 0 | $0 | 0.00% | −583−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Washington Trust Co | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| First Horizon Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| JJJ Advisors Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |